Also showed significant reductions in liver fat (up to 82.4%) and improvements in metabolic parameters Phase 3 (TRIUMPH-4) : The Phase 3 TRIUMPH-4 trial confirmed and exceeded Phase 2 results, demonstrating 28.7% mean weight loss at 68 weeks with the 12 mg dose -- the highest reported for any metabolic peptide in a Phase 3 trial Phase 3 program : Additional Phase 3 trials ongoing for obesity (TRIUMPH-1) and type 2 diabetes (TRANSCEND) MASLD/MASH : Specific trials underway evaluating liver-related endpoints Phase 3 TRIUMPH-4 data have confirmed the Phase 2 promise, though the full Phase 3 program across all indications is still ongoing
Administered by Licensed Medical Professionals
Starting at $349 - no hidden travel fees PERFORMANCE & BEAUTY INFUSIONS Formulations crafted to enhance physical performance, accelerate recovery, and support healthy skin, hair, and nails
Cold exposure and exercise timing Brief cold exposure (cold showers, cold water immersion) has been shown to activate brown adipose tissue and increase GLP-1 secretion in several human studies
ROS production was analyzed by a flow cytometry
10.1016/j.cmet.2015.12.006 154 PeetersT